Table 3.
Univariate and multivariate analysis for postoperative morbidity in patients with colonic Crohn’s disease
| Postoperative morbidity | ||||||
|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | |||||
| Variable | OR | 95% CI | p | OR | 95% CI | p |
| Age | 1.016 | 0.992–1.04 | 0.193 | |||
| Sex (female) | 0.663 | 0.318–1.375 | 0.271 | |||
| BMI | 0.948 | 0.866–1.032 | 0.229 | |||
| ASA grade ≥ 3 | 1.883 | 0.808–4.425 | 0.142 | |||
| Recurrent CD | 1.256 | 0.605–2.635 | 0.542 | |||
| Main procedure | 1.072 | 0.812–1.419 | 0.626 | |||
| Montreal B = 3 | 2.045 | 0.919–4.591 | 0.080 | 1.357 | 0.527–3.490 | 0.527 |
| Montreal L = 3 | 0.560 | 0.259–1.186 | 0.134 | |||
| Perianal disease | 0.927 | 0.454–1.888 | 0.834 | |||
| Preoperative steroids | 0.794 | 0.368–1.68 | 0.551 | |||
| Preoperative immunosuppression | 3.138 | 1.011–10.838 | 0.054 | 2.825 | 0.652–12.246 | 0.165 |
| Preoperative anti-TNF | 3.150 | 1.302–7.952 | 0.012 | 2.967 | 0.944–9.323 | 0.063 |
| Preoperative TPN | 1.127 | 0.405–3.029 | 0.813 | |||
| Access (minimally invasive) | 0.382 | 0.180–0.809 | 0.012 | 0.344 | 0.144–0.826 | 0.017 |
BMI body mass index, ASA American Society of Anaesthesiologists, OR odds ratio, CI confidence interval, TNF tumor necrosis factor, TPN total parenteral nutrition